Advertisement
Home Tags Heart / Stroke-Related: Misc.

Tag: Heart / Stroke-Related: Misc.

The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

For heart patients who can't have device implanted
Stroke risk appears to more than double in the first week following a shingles diagnosis

Risk of CV Events Up After Shingles Diagnosis in Seniors

Chance of stroke, myocardial infarction increased most in the first week after diagnosis
More frequent monitoring may be required when patients are taking both acenocoumarol and levofloxacin due to the possibility of an adverse interaction

Interaction Described Between Acenocoumarol, Levofloxacin

Probable interaction described in five patients, all of whom had atrial fibrillation
Guidelines have been formulated for arterial conduits for coronary artery bypass graft surgery

Guidelines Formulated for Arterial Conduits in CABG

Use of arterial grafts should be part of the heart team discussion for determining optimal surgical approach
Children with allergic disease may face as much as a doubling of their risk of hypertension and hyperlipidemia -- even if they aren't overweight

Pediatric Allergic Disease May Up Cardiovascular Risk

Findings held even after adjustment for obesity
β-blockers and angiotensin-converting enzyme inhibitors can prevent heart damage in breast cancer patients as they undergo chemotherapy

SABCS: β-Blockers, ACEIs May Protect Heart During Chemo

May also lower risk of complications that can interrupt breast cancer treatment
Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist treatments

Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs

Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide
Very old patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (PCI) have increased rates of PCI failure

Poor PCI Outcomes Up for Very Old With STEMI

However, successful percutaneous coronary intervention benefits all age groups
The addition of lixisenatide to usual care does not impact the rate of major cardiovascular events or other serious adverse events among patients with type 2 diabetes and a recent acute coronary syndrome

Lixisenatide Doesn’t Affect Cardiovascular Risk in T2DM

Findings among patients with type 2 diabetes and recent acute coronary syndrome
Plasma prekallikrein is associated with vascular disease risk in type 1 diabetes

Plasma Prekallikrein May Be Vascular Risk Factor in T1DM

Positive association between plasma PK and internal carotid intima-media thickness progression